Man Diagnosed Own R-CPD After Years of Inconclusive Care
A patient identified his inability to belch through research, highlighting long-standing medical diagnostic delays.
Updated on Sept. 25, 2026 in Autism

Live Poll
Do you trust online medical information to help you manage your own health symptoms?
In April 2026, a case report detailed how a man in his 30s successfully diagnosed his own retrograde cricopharyngeus dysfunction (R-CPD) after years of medical testing. The condition, which prevents the cricopharyngeus muscle from relaxing to allow air to escape, remained undiagnosed despite the patient suffering from chronic throat gurgling and abdominal swelling.
Why it matters
This case underscores the challenges many face with R-CPD, as research indicates that 90 percent of patients feel they did not receive adequate help from clinicians before obtaining a diagnosis. The story highlights the importance of patient advocacy in navigating rare conditions that were only officially named in 2019.
A 2020 follow-up study of 200 patients found that 99.5 percent gained the ability to burp following botulinum toxin treatment. Meanwhile, a 2026 review identified that 55 percent of R-CPD patients experienced symptoms dating back to childhood.
The players
Johns Hopkins
This major research institution has conducted significant studies regarding the delays patients face in receiving an accurate R-CPD diagnosis.
University of Southern California
The institution provided a medical report detailing a patient who experienced specific side effects, including swallowing difficulties, following botulinum toxin therapy.
Cureus
This peer-reviewed medical journal published the atypical case report concerning the patient who self-diagnosed his condition.
The details
The patient, who also has Tourette syndrome, utilized online research to identify his symptoms after struggling with excessive gas and throat noises. Treatment for the condition involves injecting botulinum toxin into the cricopharyngeus muscle to force relaxation, though one report from the University of Southern California noted a patient who developed swallowing difficulties after two 40-unit injections.
Timeline
The inability to belch was first described in medical literature in 1987.
Retrograde cricopharyngeus dysfunction was officially named and codified in 2019.
A follow-up study of 200 patients was published in 2020.
A Johns Hopkins review on R-CPD diagnosis delays was published in 2024.
The patient case report was published in the journal Cureus in April 2026.
The Big Picture
The medical understanding of this condition follows a pattern established by the 2019 official codification of retrograde cricopharyngeus dysfunction. This shift allows clinicians to move away from inconclusive testing toward standardized, effective botulinum toxin treatments.
Patients experiencing chronic throat gurgling and abdominal bloating may consider discussing R-CPD with a specialist as a potential cause for their symptoms. For those diagnosed, botulinum toxin injections represent a standard first-line treatment that has shown high success rates in enabling belching.
The takeaway
Self-advocacy remains a critical component of healthcare for patients dealing with conditions that lack long-term clinical awareness. Individuals who feel their symptoms are being dismissed should continue to seek second opinions or evidence-based literature to facilitate productive conversations with their doctors.
Further reading
Learn more about evolving diagnostic criteria for complex conditions in our Autism section.
Source note: This article includes information reported by Medical Daily.
Live Poll
Do you trust online medical information to help you manage your own health symptoms?



